Skip to content

Debt-to-equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.7×0.0×
Glaukos logo
GlaukosGKOS
0.2×0.0×
AbbVie logo
AbbVieABBV
46.6×+38.6×
Bausch + Lomb logo
Bausch + LombBLCO
0.8×0.0×
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
0.3×0.0×
Boston Scientific logo
Boston ScientificBSX
-0.5×

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Current ratio5.9×-4.6×

Where this comes from

Calculated from Sight Sciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s debt-to-equity?
Sight Sciences, Inc. (SGHT) reported debt-to-equity of 0.8× in Q1 2026.
How has Sight Sciences, Inc.'s debt-to-equity changed year-over-year?
Sight Sciences, Inc.'s debt-to-equity increased by 45.5% year-over-year, from 0.5× to 0.8×.
What is the long-term trend for Sight Sciences, Inc.'s debt-to-equity?
Over 4 years (2021 to 2025), Sight Sciences, Inc.'s debt-to-equity has grown at a 44.2% compound annual growth rate (CAGR), from 0.1× to 0.6×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.